Meet the top 11 gene-editing biotechs


Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:

If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let’s get to it…

A scientist wearing a white coat and pouring liquid into a beaker at Intellia Therapeutics' lab in Cambridge, Massachusetts.
Therapeutics is developing Crispr-based gene-editing medicines that could potentially cure diseases. Intellia

11 biotechs leading the gene-editing revolution, aiming to cure diseases with single treatments

Find the whole list here>>

Castor CEO Derk Arts stands in front of a monitor with a slide presentation and teleconferencing participants as three people sitting on couches look on
CEO Derk Arts, center, goes through slides about the clinical trial company’s COVID-19 work. Castor

This entrepreneur thinks computer simulations could replace human drug-trial participants by 2035. See the pitch deck that helped his startup raise $US45 ($AU61) million.

Get the full presentation>>

Nurse flu vaccine

Groups representing millions of healthcare workers demand vaccine mandates for doctors, nurses, and others in medical fields: ‘The nation depends on it’

Check it out>>

More stories we’re reading:

Sponsored event invite: Join Dr. David Shulkin, ninth secretary, US Department of Veteran Affairs, for a conversation that convenes health tech innovators and regulatory bodies at this free virtual event, “Regulating Healthcare at the Speed of Life,” sponsored by, on July 29, 12pm ET. Register here.

– Lydia